Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| EYEPOINT | 3 | 20 | 0,00 % | ||
| IOVANCE BIOTHERAPEUTICS | 3 | - | +0,98 % | ||
| REGENXBIO | 2 | - | -0,71 % | ||
| AMGEN | 1 | 27 | -0,85 % | ||
| INCYTE | 1 | 25 | -0,33 % | ||
| BIONTECH | 1 | 13 | +0,26 % | ||
| IMMUNITYBIO | 1 | 3 | +0,30 % | ||
| CYTOMX THERAPEUTICS | 1 | 2 | +1,30 % | ||
| ARCELLX | 1 | 2 | +0,40 % | ||
| OCULAR THERAPEUTIX | 1 | 1 | -1,94 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 21:06 | Prothena Corporation plc: Prothena Partners Present Data Supporting Next Generation Treatments for Parkinson's and Alzheimer's Disease at AD/PD 2026 | 98 | Business Wire | Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced... ► Artikel lesen | |
| 18:26 | Jim Cramer on ImmunityBio: "That Stock Is Part of the Magical Thinking Era" | 2 | Insider Monkey | ||
| 15:30 | EyePoint sues Ocular over claims related to lead asset | 2 | Seeking Alpha | ||
| 11:01 | Here's Why Grail Shares Crushed the Market This Week | 2 | The Motley Fool | ||
| 09:50 | Samstag Meldung zu BIONTECH SE ADR - Jetzt wird's spannend! | 18 | Maximilian Berger | ||
| 08:24 | Omeros Corporation: Omeros Announces Upcoming Presentation at EBMT 2026 Highlighting Advances in TA-TMA Treatment | 418 | Business Wire | Omeros Corporation (NASDAQ: OMER) today announced that it will host an industry session at the 52nd Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) on March 22,... ► Artikel lesen | |
| 00:48 | Incyte wird auf der Jahrestagung 2026 der American Academy of Dermatology (AAD) die neuesten Daten aus der Hidradenitis suppurativa-Forschung vorstellen | 437 | Business Wire | Aktuelle, neu veröffentlichte 54-Wochen-Daten zur Behandlung von Hidradenitis suppurativa mit Pavorcitinib (STOP-HS1 STOP-HS2) werden im Mittelpunkt stehen
Die vorgestellten Abstracts über die Ruxolitinib-Creme... ► Artikel lesen | |
| 00:35 | EyePoint sues rival Ocular Therapeutix, alleging false claims about eye drug | 6 | Reuters | ||
| Fr | Iovance Biotherapeutics: Aufsichtsratsmitglied Wendy Yarno kündigt Rücktritt an | 7 | Investing.com Deutsch | ||
| Fr | Regenxbio und GlaxoSmithKline beenden Streit um Lizenzgebühren mit 10-Millionen-Dollar-Vergleich | 5 | Investing.com Deutsch | ||
| Fr | Iovance Biotherapeutics, Inc.: Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) | 4 | GlobeNewswire (USA) | ||
| Fr | How Amgen Makes Money | 3 | Investopedia | ||
| Fr | REGENXBIO Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| Fr | IOVANCE BIOTHERAPEUTICS, INC. - 8-K, Current Report | 2 | SEC Filings | ||
| Fr | Ultragenyx Pharmaceutical Inc.: Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | 5 | GlobeNewswire (USA) | ||
| Fr | Zevra Therapeutics Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4) | 1 | GlobeNewswire (USA) | ||
| Fr | EyePoint, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| Fr | Jefferies Raises CytomX Therapeutics (CTMX) Price Target to $16 | 21 | Insider Monkey | ||
| Fr | Arcellx-Aktie erreicht Rekordhoch von 114,82 US-Dollar | 1 | Investing.com Deutsch | ||
| Fr | argenx SE: argenx announces Annual General Meeting of Shareholders on May 6, 2026 | 3 | GlobeNewswire (USA) |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.